Biotech

All Articles

OS Therapies refiles $6M IPO to fund HER2 medication, preclinical ADCs

.Operating system Therapies will definitely specify on the NYSE American supply swap this morning vi...

ALX's fizzling CD47 action fee delivers sell spiraling down

.ALX Oncology's stage 2 stomach cancer reaction price has compromised. After observing its own CD47 ...

Ionis axes eye disease coming from intendeds of Roche-partnered possibility after information dissatisfy

.Another of Ionis Pharmaceuticals' key midphase readouts has fallen short of expectations, causing t...

Biogen's chief executive officer pointed out no high-risk deals in 2023. He prepares to be daring

.While Biogen's pharma peers are actually searching for late-stage assets with little threat, chief ...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Biography has actually been a biotech seeking a pipe after it ditched its lead possessions o...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually handed back civil liberties to a very early Alzheimer's health condition system...

Takeda water faucets new head people oncology business-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable management hirings, shootings as...

Vertex, beaten by AATD again, loses 2 assets on throw out heap

.Vertex's effort to deal with an unusual hereditary disease has hit an additional setback. The biote...

Vir increases 3 T-cell engagers from Sanofi, lays off 25% of staff

.Vir Biotechnology's second-quarter earnings record wasn't except large updates. The company invited...

Galapagos stops briefly CAR-T cell therapy trial over Parkinsonism case

.Galapagos has actually paused registration in a trial of a BCMA-directed CAR-T cell treatment, push...